Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Actinium Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Actinium Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
NovoCure: The Next Big Healthcare Acquisition via Seeking Alpha
Sigilon Therapeutics (SGTX) Presents At 20th Annual Virtual Healthcare Conference - Slideshow via Seeking Alpha
Olema Pharmaceuticals (OLMA) Investor Presentation - Slideshow via Seeking Alpha
Tonix Pharmaceuticals Holding (TNXP) Investor Presentation - Slideshow via Seeking Alpha
BioSig Technologies (BSGM) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow via Seeking Alpha
AngioDynamics (ANGO) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow via Seeking Alpha
Ionis Pharmaceuticals Inc (IONS): Price Now Near $40.46; Daily Chart Shows Downtrend on 20 Day Basis via ETF Daily News
Anika Therapeutics (ANIK) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow via Seeking Alpha
Sutro Biopharma (STRO) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow via Seeking Alpha
Cardiovascular Systems (CSII) Presents At 20th Annual Needham Healthcare Conference - Slideshow via Seeking Alpha
Actinium Pharmaceuticals Inc Performance
Active Alerts for IEX:ATNM
You don't have any alerts set for IEX:ATNM.
About Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Real-time ATNM to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.